Join our email list for e-newsletter, upcoming events & information
Home
About
Learn
Advocate
Connect
Resources
More
Alpha PRRT with Pb212 (all NET)
Alpha PRRT with Ac225 (GEPNETs only)
Lu177 DOTATATE + M3814 (Peposertib) (GEPNETs)
Lu177 DOTATATE + Olaparib (GEPNETs)
Lu177 DOTATATE + Triapine (GEPNETs)
Lu177 DOTATATE + Cabozantanib (all NET)
COMPOSE (GEPNETS)
ComPareNET Lu177 vs CAPTEM in PNETs
Lu-177 DOTATATE vs Everolimus in Lung NETs
NETTER-P: Lutathera in Adolescent Patients
CABINET: Cabozantinib in Advanced pNET and Carcinoid Tumors
SWOG S2104: Adjuvant CAPTEM for High Risk pNET
Belzutifan/MK-6482 in PNET + PPGL + VHL
CDK4/6 Abemaciclib
SORRENTO: Subcutaneous Octreotide for GEPNETs
Surviving Long Peptide Vaccine (SurVaxM) in Metastatic NETs